Close Menu
World Economist – Global Markets, Finance & Economic Insights
  • Home
  • Economist Impact
    • Economist Intelligence
    • Finance & Economics
  • Business
  • Asia
  • China
  • Europe
  • Economy
  • USA
    • Middle East & Africa
    • Highlights
  • This week
  • World Economy
    • World News
What's Hot

Renault leverages Shanghai development centre for cars aimed at markets outside Europe

May 25, 2025

EU urges Trump to return to 90-day trade negotiation period

May 25, 2025

Pope Leo prays for Chinese Catholics to be in communion with Rome

May 25, 2025
Facebook X (Twitter) Instagram
Sunday, May 25
Facebook X (Twitter) Instagram
World Economist – Global Markets, Finance & Economic Insights
  • Home
  • Economist Impact
    • Economist Intelligence
    • Finance & Economics
  • Business
  • Asia
  • China
  • Europe
  • Economy
  • USA
    • Middle East & Africa
    • Highlights
  • This week
  • World Economy
    • World News
World Economist – Global Markets, Finance & Economic Insights
Home » Novo Nordisk launches $499 Wegovy cash option and home delivery
USA

Novo Nordisk launches $499 Wegovy cash option and home delivery

adminBy adminJuly 1, 2007No Comments2 Mins Read
Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
Share
Facebook Twitter Pinterest Email Copy Link
Post Views: 38


Novo Nordisk (NVO) announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery.

The move follows competitor Eli Lilly (LLY), which similarly announced a $499 cash program for its weight-loss drug Zepbound.

The two GLP-1 market leaders see the need to launch more access points to meet ongoing demand for the drugs. Especially after the FDA determined that their products, also known by their active ingredients — semaglutide for Wegovy and tirzepatide for Zepbound — are no longer in shortage, starting a countdown clock to unbranded knockoffs sold by compounding pharmacies.

FILE PHOTO: Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo
Injection pens and boxes of Novo Nordisk’s weight-loss drug Wegovy. (Reuters/Victoria Klesty/Illustration/File Photo) · REUTERS / Reuters

The new prices from both companies provide a 50% or more discount from the known list prices. Wegovy, for example, is listed for around $1,350 per month. but most patients pay less depending on their insurance coverage.

Novo Nordisk’s stock jumped more than 4% following the news Wednesday.

NYSE – Delayed Quote • USD

NVO LLY

The new cash price is only available to certain patients — those who are uninsured or those who have commercial insurance but do not have coverage for the weight-loss drugs. The new program is being launched under a new business segment called NovoCare Pharmacy.

“Today, over 55 million people in the US have coverage specifically for weight management medicines, and 90% of Wegovy patients with coverage pay $0 to $25 a month for Wegovy,” said Dave Moore, president of Novo Nordisk’s North America business, in a statement Wednesday.

Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee on social media platforms X, LinkedIn, and Bluesky @AnjKhem.

Click here for in-depth analysis of the latest health industry news and events impacting stock prices



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
admin
  • Website

Related Posts

USA

EU urges Trump to return to 90-day trade negotiation period

May 25, 2025
USA

Federal Reserve’s Jay Powell urges US university students to protect democracy

May 25, 2025
USA

Oil chiefs warn of end to US shale boom

May 25, 2025
USA

How is the Federal Reserve reacting to Donald Trump’s trade war?

May 25, 2025
USA

SoftBank’s Masayoshi Son floats idea of US-Japan sovereign wealth fund

May 25, 2025
USA

Donald Trump makes risky bet by rekindling his trade war with the EU

May 24, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Pakistan allocates 2,000 MW to Bitcoin mining, AI data centers in bold digital economy push – Business & Finance

May 25, 2025

Govt can’t levy FED on alcoholic beverages: expert – Business & Finance

May 24, 2025

Prices of majority of kitchen items show downward trend – Business & Finance

May 24, 2025

Restrictive trade practices may attract Rs75 million fine, says CCP – Markets

May 24, 2025
Latest Posts

First power equipment dashboard unveiled to boost industry – Business

May 25, 2025

Pakistan, IMF agree on budget blueprint – Business

May 25, 2025

Sales tax ‘largest’ contributor to inequality, poverty: World Bank – Business

May 24, 2025

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Recent Posts

  • Renault leverages Shanghai development centre for cars aimed at markets outside Europe
  • EU urges Trump to return to 90-day trade negotiation period
  • Pope Leo prays for Chinese Catholics to be in communion with Rome
  • Federal Reserve’s Jay Powell urges US university students to protect democracy
  • GOP senators criticize House budget bill over deficit concerns

Recent Comments

No comments to show.

Welcome to World-Economist.com, your trusted source for in-depth analysis, expert insights, and the latest news on global finance and economics. Our mission is to provide readers with accurate, data-driven reports that shape the understanding of economic trends worldwide.

Latest Posts

Renault leverages Shanghai development centre for cars aimed at markets outside Europe

May 25, 2025

EU urges Trump to return to 90-day trade negotiation period

May 25, 2025

Pope Leo prays for Chinese Catholics to be in communion with Rome

May 25, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • June 2024
  • October 2022
  • March 2022
  • July 2021
  • February 2021
  • January 2021
  • November 2019
  • April 2011
  • January 2011
  • December 2007
  • July 2007

Categories

  • AI & Tech
  • Asia
  • Banking
  • Business
  • Business
  • China
  • Climate
  • Computing
  • Economist Impact
  • Economist Intelligence
  • Economy
  • Editor's Choice
  • Europe
  • Europe
  • Featured
  • Featured Business
  • Featured Climate
  • Featured Health
  • Featured Science & Tech
  • Featured Travel
  • Finance & Economics
  • Health
  • Highlights
  • Markets
  • Middle East
  • Middle East & Africa
  • Middle East News
  • Most Viewed News
  • News Highlights
  • Other News
  • Politics
  • Russia
  • Science
  • Science & Tech
  • Social
  • Space Science
  • Sports
  • Sports Roundup
  • Tech
  • This week
  • Top Featured
  • Travel
  • Trending Posts
  • Ukraine Conflict
  • Uncategorized
  • US Politics
  • USA
  • World
  • World & Politics
  • World Economy
  • World News
© 2025 world-economist. Designed by world-economist.
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.